Advanced Filters
noise

Canker Sores Clinical Trials

A listing of Canker Sores medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 46 clinical trials

Domperidone in Treating Patients With Gastrointestinal Disorders

This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.

16 - 100 years of age Both Phase 3
M Melina S Hansen, MD

Pathophysiology of Diabetic Gastroparesis

The goal of this study is to explore the pathophysiology of diabetic gastroparesis by conducting an exploratory cohort study. Participants will be type 1 diabetes patients with and without gastroparesis. Investigators will investigate Differences in nervefiber density and morphology Cellular and transcriptional changes and indices of glucosemetabolism between groups

18 - 85 years of age Both Phase N/A
T Tennekoon Karunaratne, MD,PhD

Thoracic Neuromodulation for Diabetic Gastroparesis

The global incidence of diabetes is rising. Gastroparesis is a significant complication of diabetes that results in debilitating symptoms and affects quality of life. Current treatment options for diabetic gastroparesis are limited. Significant visceral afferent neuropathy is associated with diabetic gastroparesis and sympathetic overactivity is seen in nausea, both type …

18 - 85 years of age Both Phase N/A
F Faming Zhang, MD, PhD

Washed Microbiota Transplantation for Diabetic Gastroparesis

This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.

18 - 100 years of age Both Phase N/A
B Brian Lacy, MD

Rifaximin in Patients With Diabetic Gastroparesis

Researchers are trying to determine if subjects with diabetic gastroparesis and symptoms of bloating will have a greater improvement in bloating symptoms when treated with rifaximin.

18 - 75 years of age Both Phase 2
J Jorge Araujo-Duran, MD

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

18 - 100 years of age Both Phase N/A
H Hannah Pearson

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastroparesis in adult patients. The main questions it aims to answer are: To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with …

18 - 100 years of age Both Phase 2

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the …

- 100 years of age Both Phase N/A
H Hayat Mousa, MD

BSGM to Evaluate Patients With GI Symptoms

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach …

8 - 25 years of age Both Phase N/A
D Dennis Yang, MD

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI